-
My Account
In App
My Account
Not Rated
|
Fund Size
(0% of Investment in Category)
|
Expense Ratio
(0.28% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 12-Nov-25 | 10076.30 | 0.76% | - | 0.17% | 43/352 |
| 1 Month | 17-Oct-25 | 10018.40 | 0.18% | - | 1.09% | 306/351 |
| 3 Month | 19-Aug-25 | 10176.10 | 1.76% | - | 3.39% | 232/342 |
| Since Inception | 20-Jun-25 | 10572.60 | 5.73% | 14.31% | 10.45% | 268/342 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 25.2 | 18.15% | 0.48% | 18.51% (Jul 2025) | 0% (Nov 2024) | 14.89 k | 557.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 12.1 | 8.72% | 1.12% | 8.73% (Jun 2025) | 0% (Nov 2024) | 1.79 k | 67.00 |
| Max Healthcare Institute Ltd. | Hospital | 12.1 | 8.69% | -0.02% | 9.58% (Jun 2025) | 0% (Nov 2024) | 10.50 k | 392.00 |
| Cipla Ltd. | Pharmaceuticals | 11.9 | 8.60% | -0.29% | 9.32% (Aug 2025) | 0% (Nov 2024) | 7.95 k | 298.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 11 | 7.90% | 0.03% | 8.02% (Aug 2025) | 0% (Nov 2024) | 1.43 k | 53.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 10.3 | 7.43% | -0.41% | 8% (Aug 2025) | 0% (Nov 2024) | 8.61 k | 322.00 |
| Fortis Healthcare Ltd. | Hospital | 7.5 | 5.43% | 0.12% | 5.43% (Oct 2025) | 0% (Nov 2024) | 7.36 k | 276.00 |
| Lupin Ltd. | Pharmaceuticals | 6.7 | 4.84% | -0.02% | 4.86% (Sep 2025) | 0% (Nov 2024) | 3.42 k | 128.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 5.3 | 3.79% | -0.17% | 3.96% (Sep 2025) | 0% (Nov 2024) | 1.48 k | 55.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 5.2 | 3.77% | 0.33% | 3.77% (Oct 2025) | 0% (Nov 2024) | 5.49 k | 205.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.83% |
| Net Receivables | Net Receivables | -0.81% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 63 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 11 is/are ranked 3 * , and 38 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| DSP Midcap Fund - Direct Plan - Growth | 3 | 19609.01 | 2.15 | 2.60 | 6.56 | 7.76 | 21.48 |
| DSP Liquidity Fund - Direct Plan - Growth | 3 | 19054.79 | 0.50 | 1.47 | 3.03 | 6.74 | 7.08 |
| DSP ELSS Tax Saver Fund - Direct Plan - Growth | 5 | 17241.31 | 2.68 | 4.58 | 4.51 | 9.40 | 20.94 |
| DSP Small Cap Fund - Direct Plan - Growth | 3 | 16867.93 | 2.79 | 0.77 | 7.09 | 5.07 | 22.00 |
| DSP Large & Mid Cap Fund - Direct Plan - Growth | 4 | 16530.07 | 2.62 | 4.39 | 4.85 | 9.14 | 21.61 |
| DSP Flexi Cap Fund - Direct Plan - Growth | 3 | 12197.68 | 1.44 | 3.77 | 4.12 | 7.08 | 19.01 |
| DSP Aggressive Hybrid Fund - Direct Plan - Growth | 4 | 11909.72 | 0.44 | 2.18 | 1.97 | 8.22 | 17.34 |
| DSP Savings Fund - Direct Plan - Growth | 4 | 7524.16 | 0.56 | 1.55 | 3.34 | 7.40 | 7.49 |
| DSP Large Cap Fund - Direct Plan - Growth | 5 | 6933.59 | 1.16 | 3.57 | 3.43 | 9.45 | 18.92 |
| DSP Arbitrage fund - Direct Plan - Growth | 3 | 6447.92 | 0.58 | 1.61 | 3.22 | 6.91 | 7.69 |
